Rashi Peripherals Issues Postal Ballot Notice for Director Appointments with E-Voting Period from March 26-April 24, 2026
Rashi Peripherals Limited has issued a postal ballot notice seeking shareholder approval for appointing Rajesh Goenka as Whole-Time Director and CEO with maximum annual remuneration of ₹14.00 crore, and Dr. Indumati Gopinathan as Independent Director. The company published newspaper advertisements on March 26, 2026, in Financial Express and Navshakti newspapers as per SEBI regulations.

*this image is generated using AI for illustrative purposes only.
Rashi Peripherals Limited has issued a comprehensive postal ballot notice dated February 3, 2026, seeking shareholder consent for the appointment of two directors through a special resolution process. The company has engaged MUFG Intime India Private Limited as the Registrar and Share Transfer Agent to facilitate the e-voting process for eligible shareholders.
E-Voting Schedule and Process
The remote e-voting period has been scheduled to provide shareholders adequate time for participation in the decision-making process. Mrs. Ragini Chokshi (FCS 2390, CP No. 1436), a Practicing Company Secretary from Mumbai, has been appointed as the Scrutinizer to ensure fair and transparent conduct of the postal ballot process.
| Parameter: | Details |
|---|---|
| Voting Commencement: | Thursday, March 26, 2026 at 09:00 A.M. (IST) |
| Voting Conclusion: | Friday, April 24, 2026 at 05:00 P.M. (IST) |
| Cut-off Date: | Friday, March 20, 2026 |
| Scrutinizer: | Mrs. Ragini Chokshi (FCS 2390, CP No. 1436) |
| RTA: | MUFG Intime India Private Limited |
Proposed Director Appointments
The postal ballot notice encompasses two special resolutions for director appointments, both requiring shareholder approval through the e-voting mechanism.
Appointment of Mr. Rajesh Goenka as Whole-Time Director and CEO
Mr. Rajesh Goenka (DIN: 10985108) has been proposed for appointment as Whole-Time Director and Chief Executive Officer for a five-year term. The Board of Directors, based on the Nomination and Remuneration Committee's recommendation, approved his appointment as Additional Director on February 3, 2026. Mr. Goenka brings over 25 years of extensive experience in sales and marketing, holding a Bachelor's degree in Chemical Engineering from Pune University. He has been associated with the company since 2008 and was previously designated as CEO on September 23, 2022.
| Remuneration Component: | Amount |
|---|---|
| Basic Salary: | ₹4,83,000 per month |
| House Rent Allowance: | ₹2,41,500 per month |
| Special Allowance: | ₹21,99,115 per month |
| Provident Fund: | 12% of Basic Salary |
| Gratuity: | ₹2,78,646 per annum |
| NPS Contribution: | ₹50,000 per annum |
| Maximum Annual Remuneration: | Up to ₹14.00 crore |
| Term Duration: | February 3, 2026 to February 2, 2031 |
Appointment of Dr. Indumati Gopinathan as Independent Director
Dr. Indumati Gopinathan (DIN: 06779331) has been proposed for appointment as an Independent Director. She is an experienced pathologist with MBBS and MD degrees from Seth G.S. Medical College, Mumbai, and currently serves as an Independent Director at Thyrocare Technologies Limited. Her expertise spans pathology department leadership, ocular pathology, uropathology, and healthcare governance.
| Appointment Details: | Information |
|---|---|
| Position: | Independent Director |
| Tenure Start: | February 3, 2026 |
| Tenure End: | Conclusion of 38th AGM in 2027 |
| Age: | 69 Years |
| Current Directorships: | Thyrocare Technologies Limited |
| Shareholding: | Nil |
Newspaper Advertisement Publication
The company published newspaper advertisements regarding the postal ballot notice on March 26, 2026, in compliance with Regulation 30 read with Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The advertisements were published in Financial Express (English Language) and Navshakti (Marathi Language). The announcement is also available on the company's website at www.rptechindia.com/investor .
| Publication Details: | Information |
|---|---|
| English Newspaper: | Financial Express |
| Regional Newspaper: | Navshakti (Marathi) |
| Publication Date: | March 26, 2026 |
| Website Link: | www.rptechindia.com/investor |
Shareholder Eligibility and Compliance
The postal ballot notice is being sent electronically to shareholders whose email addresses are registered with the company or depositories and whose names appear in the Register of Members as on the cut-off date of Friday, March 20, 2026. The voting rights will be proportionate to shareholders' paid-up equity share capital as on the cut-off date.
The company has ensured compliance with relevant regulations including Section 110 of the Companies Act, 2013, SEBI Listing Regulations, and various MCA circulars. Results will be uploaded on stock exchanges within two working days from the conclusion of the postal ballot and will be available on the company's website and MUFG Intime's platform.
Key Compliance and Documentation
Both proposed directors have submitted all required declarations and consents as mandated under the Companies Act, 2013 and SEBI regulations. The company has received notices under Section 160 of the Companies Act, 2013 from members proposing their candidatures. All necessary forms including DIR-2, DIR-8, and declarations regarding non-disqualification have been properly filed and verified.
Historical Stock Returns for Rashi Peripherals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +2.75% | +1.15% | -1.18% | +13.79% | +19.67% | +13.44% |
How might the appointment of a new CEO with 25 years of sales and marketing experience impact Rashi Peripherals' market expansion strategy and revenue growth trajectory?
What strategic initiatives could Dr. Indumati Gopinathan's healthcare governance expertise bring to Rashi Peripherals' board, particularly given her background in pathology and medical technology?
Will the ₹14 crore maximum annual remuneration package for the CEO signal increased investor confidence or raise concerns about executive compensation relative to company performance?


































